Free Trial

Transcat (TRNS) Financials

Transcat logo
$75.16 -0.17 (-0.23%)
Closing price 05/6/2026 04:00 PM Eastern
Extended Trading
$75.21 +0.05 (+0.07%)
As of 05/6/2026 07:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Transcat

Annual Income Statements for Transcat

This table shows Transcat's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 3/28/2015 3/26/2016 3/25/2017 3/31/2018 3/30/2019 3/28/2020 3/27/2021 3/26/2022 3/25/2023 3/30/2024 3/29/2025
Net Income / (Loss) Attributable to Common Shareholders
4.03 4.12 4.52 5.92 7.15 8.07 7.79 11 11 14 15
Consolidated Net Income / (Loss)
4.03 4.12 4.52 5.92 7.15 8.07 7.79 11 11 14 15
Net Income / (Loss) Continuing Operations
4.03 4.12 4.52 5.92 7.15 8.07 7.79 11 11 14 15
Total Pre-Tax Income
6.42 6.01 7.16 7.95 9.24 9.73 9.98 13 13 18 18
Total Operating Income
6.77 6.30 7.93 9.03 10 11 11 14 16 20 18
Total Gross Profit
29 29 35 37 39 42 46 58 68 84 89
Total Revenue
124 122 144 155 161 173 173 205 231 259 278
Operating Revenue
124 122 144 155 161 173 173 205 231 259 278
Total Cost of Revenue
95 93 109 118 122 131 127 147 162 176 189
Operating Cost of Revenue
95 93 109 118 122 131 127 147 162 176 189
Total Operating Expenses
22 23 27 28 29 32 35 44 52 64 72
Selling, General & Admin Expense
8.41 9.19 10 12 12 14 17 24 27 35 38
Marketing Expense
14 14 17 17 17 18 18 21 25 29 33
Total Other Income / (Expense), net
-0.35 -0.30 -0.77 -1.08 -0.99 -1.12 -1.09 -0.95 -2.76 -1.34 0.45
Interest Expense
- - - - - - - 0.81 2.42 1.84 0.80
Interest & Investment Income
- - - - - - - 0.00 0.00 0.81 0.83
Other Income / (Expense), net
-0.35 -0.30 -0.77 -1.08 -0.99 -1.12 -1.09 -0.14 -0.34 -0.32 0.43
Income Tax Expense
2.40 1.88 2.64 2.03 2.09 1.66 2.19 1.81 2.80 4.79 3.81
Basic Earnings per Share
$0.59 $0.60 $0.65 $0.83 $0.99 $1.10 $1.05 $1.52 $1.42 $1.66 $1.58
Weighted Average Basic Shares Outstanding
6.80M 6.89M 6.99M 7.12M 7.20M 7.33M 7.42M 7.50M 7.55M 8.24M 9.19M
Diluted Earnings per Share
$0.57 $0.58 $0.64 $0.81 $0.95 $1.08 $1.03 $1.50 $1.40 $1.63 $1.57
Weighted Average Diluted Shares Outstanding
7.06M 7.12M 7.11M 7.30M 7.52M 7.49M 7.55M 7.59M 7.65M 8.35M 9.25M
Weighted Average Basic & Diluted Shares Outstanding
6.87M 6.98M 7.11M 7.20M 7.30M 7.39M 7.47M 7.55M 7.64M 9.13M 9.32M

Quarterly Income Statements for Transcat

This table shows Transcat's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/24/2023 9/23/2023 12/23/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 12/27/2025
Net Income / (Loss) Attributable to Common Shareholders
2.95 0.46 3.35 6.89 4.41 3.29 2.36 4.46 3.26 1.27 -1.10
Consolidated Net Income / (Loss)
2.95 0.46 3.35 6.89 4.41 3.29 2.36 4.46 3.26 1.27 -1.10
Net Income / (Loss) Continuing Operations
2.95 0.46 3.35 6.89 4.41 3.29 2.36 4.46 3.26 1.27 -1.10
Total Pre-Tax Income
3.76 0.80 4.27 9.60 5.23 3.71 3.13 6.26 4.57 2.03 -1.44
Total Operating Income
4.64 1.64 4.29 9.20 5.10 3.74 2.10 6.94 5.34 3.51 0.09
Total Gross Profit
19 20 21 24 23 21 20 26 26 27 25
Total Revenue
61 63 65 71 67 68 67 77 76 82 84
Operating Revenue
61 63 65 71 67 68 67 77 76 82 84
Total Cost of Revenue
42 43 44 47 44 47 47 51 51 56 59
Operating Cost of Revenue
42 43 44 47 44 47 47 51 51 56 59
Total Operating Expenses
14 18 17 15 18 17 18 19 20 23 25
Selling, General & Admin Expense
7.60 12 9.12 6.97 9.76 9.29 9.46 9.73 11 13 14
Marketing Expense
6.47 6.86 7.52 7.87 7.80 8.18 8.12 9.24 9.52 11 11
Total Other Income / (Expense), net
-0.88 -0.84 -0.02 0.40 0.13 -0.02 1.03 -0.68 -0.77 -1.48 -1.53
Interest Expense
0.81 0.89 0.08 - 0.05 0.08 0.20 0.47 0.45 1.27 1.50
Interest & Investment Income
0.00 0.00 0.35 - 0.31 0.29 0.22 0.01 0.01 0.01 0.00
Other Income / (Expense), net
-0.06 0.05 -0.29 0.88 -0.13 -0.23 1.01 -0.22 -0.33 -0.21 -0.03
Income Tax Expense
0.81 0.34 0.92 2.71 0.82 0.43 0.77 1.79 1.30 0.76 -0.34
Basic Earnings per Share
$0.39 $0.06 $0.39 $0.82 $0.49 $0.36 $0.26 $0.47 $0.35 $0.14 ($0.12)
Weighted Average Basic Shares Outstanding
7.62M 7.82M 8.62M 8.24M 9.06M 9.16M 9.23M 9.19M 9.32M 9.32M 9.33M
Diluted Earnings per Share
$0.38 $0.06 $0.38 $0.81 $0.48 $0.35 $0.25 $0.49 $0.35 $0.14 ($0.12)
Weighted Average Diluted Shares Outstanding
7.76M 7.95M 8.75M 8.35M 9.20M 9.28M 9.33M 9.25M 9.39M 9.40M 9.33M
Weighted Average Basic & Diluted Shares Outstanding
7.69M 8.83M 8.83M 9.13M 9.15M 9.20M 9.31M 9.32M 9.32M 9.33M 9.33M

Annual Cash Flow Statements for Transcat

This table details how cash moves in and out of Transcat's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 3/28/2015 3/26/2016 3/25/2017 3/31/2018 3/30/2019 3/28/2020 3/27/2021 3/26/2022 3/25/2023 3/30/2024 3/29/2025
Net Change in Cash & Equivalents
0.04 0.58 0.20 -0.27 0.21 -0.29 0.06 0.84 0.14 18 -18
Net Cash From Operating Activities
4.44 11 7.54 9.87 13 12 24 18 17 33 39
Net Cash From Continuing Operating Activities
4.44 11 7.54 9.87 13 12 24 18 17 33 39
Net Income / (Loss) Continuing Operations
4.03 4.12 4.52 5.92 7.15 8.07 7.79 11 11 14 15
Consolidated Net Income / (Loss)
4.03 4.12 4.52 5.92 7.15 8.07 7.79 11 11 14 15
Depreciation Expense
3.09 3.95 6.18 5.99 6.36 6.66 7.58 9.57 11 14 19
Non-Cash Adjustments To Reconcile Net Income
0.64 0.54 0.83 1.64 1.63 1.72 2.29 2.45 3.54 4.97 2.70
Changes in Operating Assets and Liabilities, net
-3.32 2.37 -3.99 -3.68 -2.58 -4.88 5.98 -5.78 -8.23 0.45 3.21
Net Cash From Investing Activities
-11 -18 -12 -5.87 -11 -20 -10 -40 -19 -42 -84
Net Cash From Continuing Investing Activities
-11 -18 -12 -5.87 -11 -20 -10 -40 -19 -42 -84
Purchase of Property, Plant & Equipment
-3.50 -4.10 -5.25 -5.88 -7.00 -6.58 -6.62 -10 -9.41 -13 -13
Acquisitions
-7.28 -14 -6.98 0.00 -3.92 -14 -3.55 -30 -9.11 -13 -87
Sale of Property, Plant & Equipment
0.05 0.03 0.06 0.01 0.02 0.18 0.02 0.11 0.01 0.00 1.10
Other Investing Activities, net
- - - - - - - - 0.00 -16 16
Net Cash From Financing Activities
4.99 7.23 4.77 -3.98 -1.71 8.25 -13 24 0.88 27 27
Net Cash From Continuing Financing Activities
4.99 7.23 4.77 -3.98 -1.71 8.25 -13 24 0.88 27 27
Repayment of Debt
- 0.00 -1.76 -12 -4.35 -1.90 -1.98 -2.11 0.67 -45 29
Repurchase of Common Equity
-0.07 -0.13 -1.06 -0.45 -0.15 -2.82 -3.05 -6.68 -0.45 -4.91 -3.57
Issuance of Common Equity
0.47 0.45 0.64 0.93 0.29 1.73 1.18 1.49 0.66 77 1.87
Effect of Exchange Rate Changes
1.34 0.33 0.06 -0.29 0.26 0.15 - - 0.82 -0.23 0.02
Cash Interest Paid
0.23 0.24 0.69 1.02 0.91 0.94 0.86 0.78 2.26 1.24 -0.15
Cash Income Taxes Paid
2.43 1.29 1.84 2.07 1.30 1.37 1.76 3.90 1.12 3.10 7.84

Quarterly Cash Flow Statements for Transcat

This table details how cash moves in and out of Transcat's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/24/2023 9/23/2023 12/23/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 12/27/2025
Net Change in Cash & Equivalents
0.62 -0.90 34 -16 3.01 1.16 -19 -3.12 0.34 3.22 -1.61
Net Cash From Operating Activities
7.54 8.44 11 5.73 8.92 6.84 13 11 3.62 13 12
Net Cash From Continuing Operating Activities
7.54 8.44 11 5.73 8.92 6.73 13 11 3.62 13 12
Net Income / (Loss) Continuing Operations
2.95 0.46 3.35 6.89 4.41 3.29 2.36 4.46 3.26 1.27 -1.10
Consolidated Net Income / (Loss)
2.95 0.46 3.35 6.89 4.41 3.29 2.36 4.46 3.26 1.27 -1.10
Depreciation Expense
2.79 3.29 3.76 3.70 4.11 4.40 4.43 5.63 5.61 6.49 7.13
Amortization Expense
- - - - - - - - - - 0.04
Non-Cash Adjustments To Reconcile Net Income
1.08 1.45 1.21 1.23 1.45 1.07 -0.37 1.40 2.22 3.12 3.30
Changes in Operating Assets and Liabilities, net
0.72 3.24 2.59 -6.10 -1.05 -2.03 6.29 -0.86 -7.46 1.98 2.78
Net Cash From Investing Activities
-5.64 -13 -3.71 -20 -4.09 -3.86 -72 -4.04 -4.60 -87 -2.68
Net Cash From Continuing Investing Activities
-5.64 -13 -3.71 -20 -4.09 -3.86 -72 -4.04 -4.60 -87 -2.68
Purchase of Property, Plant & Equipment
-2.77 -2.68 -3.66 -4.18 -3.67 -3.96 -2.87 -2.70 -4.60 -4.43 -2.68
Acquisitions
-2.87 -10 -0.05 0.07 -16 0.10 -70 -1.34 0.00 -83 0.00
Net Cash From Financing Activities
-0.86 3.17 27 -1.68 -1.94 -1.41 40 -9.45 1.95 77 -12
Net Cash From Continuing Financing Activities
-0.86 3.17 27 -1.68 -1.94 -1.41 40 -9.45 1.95 77 -12
Repayment of Debt
-0.55 -0.56 -43 -0.57 -0.58 -0.58 39 -9.20 -0.60 -52 -12
Repurchase of Common Equity
-0.30 -1.95 - -2.66 -1.62 -1.41 -0.18 -0.36 0.00 -0.11 0.01
Issuance of Debt
-0.20 5.49 - - 0.00 - - - 2.29 129 -0.41
Issuance of Common Equity
0.20 0.19 75 1.55 0.26 0.58 0.93 0.11 0.26 0.23 0.19
Cash Interest Paid
0.82 - - -0.41 0.26 - - 0.46 0.46 0.83 -0.42
Cash Income Taxes Paid
0.11 0.99 0.79 1.22 0.06 5.47 1.33 0.98 -0.18 0.58 1.23

Annual Balance Sheets for Transcat

This table presents Transcat's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 3/28/2015 3/26/2016 3/25/2017 3/31/2018 3/30/2019 3/28/2020 3/27/2021 3/26/2022 3/25/2023 3/30/2024 3/29/2025
Total Assets
62 77 92 97 105 128 132 178 196 288 385
Total Current Assets
27 26 36 41 45 48 49 60 68 105 78
Cash & Equivalents
0.07 0.64 0.84 0.58 0.79 0.50 0.56 1.40 1.53 20 1.52
Accounts Receivable
18 18 23 26 29 32 34 40 45 48 56
Inventories, net
6.75 6.52 10 13 14 14 12 13 17 17 14
Prepaid Expenses
1.21 1.10 1.19 1.24 1.33 1.70 2.35 5.30 3.94 4.28 5.70
Plant, Property, & Equipment, net
9.40 12 16 17 20 21 22 26 29 39 50
Total Noncurrent Assets
26 38 41 39 41 59 61 92 99 143 257
Goodwill
21 29 33 33 35 42 43 65 69 106 177
Intangible Assets
3.55 8.21 7.52 5.51 5.23 7.98 7.51 15 14 20 55
Other Noncurrent Operating Assets
1.13 0.85 0.90 0.97 0.79 9.31 10 12 16 18 26
Total Liabilities & Shareholders' Equity
62 77 92 97 105 128 132 178 196 288 385
Total Liabilities
28 38 49 45 46 61 57 92 96 62 98
Total Current Liabilities
12 16 20 21 22 21 25 28 28 33 34
Short-Term Debt
- 0.00 1.43 2.14 1.90 1.98 2.07 2.16 2.25 2.34 1.82
Accounts Payable
7.70 8.14 12 14 15 12 12 14 16 11 17
Accrued Expenses
- - - - - - - 11 10 17 15
Total Noncurrent Liabilities
16 22 29 24 23 40 32 64 68 29 64
Long-Term Debt
12 19 26 21 19 28 17 46 47 1.82 31
Noncurrent Deferred & Payable Income Tax Liabilities
1.68 1.07 1.13 1.71 2.45 3.03 3.20 6.72 6.54 9.29 9.29
Other Noncurrent Operating Liabilities
2.05 1.82 1.92 1.91 1.90 8.73 3.24 11 14 18 24
Total Equity & Noncontrolling Interests
34 39 43 51 60 67 75 86 100 225 287
Total Preferred & Common Equity
34 39 43 51 60 67 75 86 100 225 287
Total Common Equity
34 39 43 51 60 67 75 86 100 225 287
Common Stock
16 16 17 19 20 22 23 28 32 146 196
Retained Earnings
19 23 27 33 40 46 53 59 69 80 93
Accumulated Other Comprehensive Income / (Loss)
-0.14 -0.36 -0.41 -0.28 -0.61 -1.01 -0.45 -0.23 -1.20 -0.95 -1.47

Quarterly Balance Sheets for Transcat

This table presents Transcat's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/24/2022 12/24/2022 6/24/2023 9/23/2023 12/23/2023 6/29/2024 9/28/2024 12/28/2024 6/28/2025 9/27/2025 12/27/2025
Total Assets
187 188 203 248 281 324 324 386 393 485 473
Total Current Assets
63 61 64 65 99 94 95 77 80 86 81
Cash & Equivalents
0.91 1.59 2.15 1.25 35 23 24 4.64 1.86 5.08 3.47
Accounts Receivable
41 38 43 45 44 48 50 52 58 63 60
Inventories, net
17 17 15 16 16 18 16 14 15 13 13
Prepaid Expenses
4.42 4.14 3.39 3.53 3.30 5.07 6.24 5.77 4.04 4.39 4.64
Plant, Property, & Equipment, net
28 28 30 36 37 46 47 50 52 58 58
Total Noncurrent Assets
96 99 110 147 145 183 181 259 261 341 335
Goodwill
66 69 77 106 106 138 138 177 177 218 218
Intangible Assets
15 15 15 23 21 26 24 58 52 85 81
Other Noncurrent Operating Assets
15 16 17 18 18 19 18 25 32 37 35
Total Liabilities & Shareholders' Equity
187 188 203 248 281 324 324 386 393 485 473
Total Liabilities
94 93 93 110 63 61 55 105 100 189 176
Total Current Liabilities
25 25 24 28 29 32 27 32 27 35 37
Short-Term Debt
2.21 2.23 2.27 2.29 2.32 2.36 2.39 2.41 1.22 0.00 0.00
Accounts Payable
14 14 12 13 11 13 13 16 13 15 17
Accrued Expenses
9.09 9.01 9.29 13 16 13 11 13 13 20 19
Total Noncurrent Liabilities
70 68 69 82 33 30 28 73 73 154 140
Long-Term Debt
49 47 46 51 2.41 1.22 0.61 39 33 112 100
Noncurrent Deferred & Payable Income Tax Liabilities
6.67 6.67 7.18 11 11 9.29 9.30 9.26 9.31 9.30 9.31
Other Noncurrent Operating Liabilities
14 14 16 20 20 19 18 24 30 33 30
Total Equity & Noncontrolling Interests
92 95 111 138 218 262 269 281 293 295 297
Total Preferred & Common Equity
92 95 111 138 218 262 269 281 293 295 297
Total Common Equity
92 95 111 138 218 262 269 281 293 295 297
Common Stock
30 31 40 68 145 180 184 195 197 199 201
Retained Earnings
64 66 72 71 74 84 86 88 96 97 96
Accumulated Other Comprehensive Income / (Loss)
-1.52 -1.12 -0.72 -1.06 -0.69 -1.10 -0.72 -1.88 -0.46 -0.75 -0.51

Annual Metrics And Ratios for Transcat

This table displays calculated financial ratios and metrics derived from Transcat's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 3/28/2015 3/26/2016 3/25/2017 3/31/2018 3/30/2019 3/28/2020 3/27/2021 3/26/2022 3/25/2023 3/30/2024 3/29/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
4.32% -1.18% 17.79% 7.81% 3.71% 7.58% 0.14% 18.24% 12.50% 12.54% 7.30%
EBITDA Growth
1.30% 4.63% 34.11% 4.43% 11.89% 5.08% 7.16% 34.19% 13.97% 22.90% 11.68%
EBIT Growth
-0.36% -6.48% 19.26% 10.94% 16.19% 5.36% 2.59% 40.25% 13.60% 22.40% -6.00%
NOPAT Growth
2.37% 1.99% 15.75% 34.29% 17.68% 13.67% -3.92% 41.19% 5.52% 13.70% -3.30%
Net Income Growth
1.05% 2.43% 9.65% 30.96% 20.65% 12.90% -3.42% 46.07% -6.08% 27.69% 6.36%
EPS Growth
5.56% 1.75% 10.34% 26.56% 17.28% 13.68% -4.63% 45.63% -6.67% 16.43% -3.68%
Operating Cash Flow Growth
-41.68% 147.40% -31.31% 30.89% 27.21% -7.96% 104.47% -25.47% -3.79% 92.41% 19.53%
Free Cash Flow Firm Growth
-178.68% -45.73% -14.02% 139.56% -43.16% -578.55% 143.71% -636.89% 94.17% -2,814.24% -239.95%
Invested Capital Growth
23.29% 23.53% 21.85% 5.37% 8.45% 21.40% 5.27% 30.57% 10.50% 31.88% 63.83%
Revenue Q/Q Growth
1.59% 0.43% 4.04% 2.65% 1.28% 0.74% 1.76% 3.60% 2.76% 3.53% 2.29%
EBITDA Q/Q Growth
3.45% -4.81% 3.92% 6.77% 1.56% 0.76% 6.54% 6.49% 6.37% 16.02% -1.47%
EBIT Q/Q Growth
3.36% -13.23% 3.18% 13.36% 0.83% 0.44% 8.74% 5.68% 10.91% 22.43% -11.91%
NOPAT Q/Q Growth
4.82% -6.58% -1.93% 19.05% 3.45% -1.48% 8.83% -0.94% 9.73% 16.86% -10.06%
Net Income Q/Q Growth
5.37% -7.45% -3.17% 20.93% 2.97% -2.03% 10.10% -1.39% 6.05% 31.03% -14.32%
EPS Q/Q Growth
7.55% -7.94% -4.48% 19.12% 2.15% -1.82% 9.57% -1.32% 6.06% 25.38% -16.93%
Operating Cash Flow Q/Q Growth
-5.13% 3.38% 1.22% 4.08% 11.13% -14.68% 24.59% -13.51% -11.78% 9.21% 14.38%
Free Cash Flow Firm Q/Q Growth
6.87% -240.06% 51.70% 573.95% -3.28% -258.96% 198.09% -49.30% 89.19% 0.97% 4.23%
Invested Capital Q/Q Growth
-2.21% 21.00% 2.65% -0.98% -0.50% 15.00% 6.47% 10.22% 3.05% 3.27% -0.09%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
23.53% 23.84% 24.30% 24.13% 24.45% 24.54% 26.61% 28.51% 29.65% 32.30% 32.13%
EBITDA Margin
7.70% 8.15% 9.28% 8.98% 9.69% 9.47% 10.13% 11.50% 11.65% 12.72% 13.24%
Operating Margin
5.47% 5.16% 5.51% 5.82% 6.36% 6.27% 6.39% 6.90% 7.05% 7.62% 6.42%
EBIT Margin
5.20% 4.92% 4.98% 5.12% 5.74% 5.62% 5.76% 6.83% 6.90% 7.50% 6.57%
Profit (Net Income) Margin
3.26% 3.38% 3.14% 3.82% 4.44% 4.66% 4.49% 5.55% 4.64% 5.26% 5.21%
Tax Burden Percent
62.68% 68.65% 63.12% 74.51% 77.37% 82.91% 78.05% 86.28% 79.25% 74.01% 79.20%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 94.21% 84.80% 94.72% 100.15%
Effective Tax Rate
37.32% 31.35% 36.88% 25.49% 22.63% 17.09% 21.95% 13.72% 20.75% 25.99% 20.80%
Return on Invested Capital (ROIC)
10.09% 8.34% 7.87% 9.37% 10.31% 10.18% 8.69% 10.37% 9.18% 8.58% 5.53%
ROIC Less NNEP Spread (ROIC-NNEP)
7.89% 7.01% 5.71% 6.08% 6.69% 6.47% 5.69% 8.15% 4.56% -3.42% 431.72%
Return on Net Nonoperating Assets (RNNOA)
2.41% 2.92% 3.11% 3.13% 2.56% 2.55% 2.27% 3.74% 2.32% -0.17% 0.14%
Return on Equity (ROE)
12.50% 11.26% 10.99% 12.50% 12.88% 12.73% 10.96% 14.11% 11.50% 8.40% 5.67%
Cash Return on Invested Capital (CROIC)
-10.77% -12.71% -11.82% 4.15% 2.20% -9.16% 3.56% -16.15% -0.79% -18.92% -42.86%
Operating Return on Assets (OROA)
11.07% 8.65% 8.49% 8.41% 9.14% 8.34% 7.67% 9.04% 8.52% 8.06% 5.44%
Return on Assets (ROA)
6.94% 5.94% 5.36% 6.27% 7.07% 6.91% 5.99% 7.34% 5.72% 5.65% 4.31%
Return on Common Equity (ROCE)
12.50% 11.26% 10.99% 12.50% 12.88% 12.73% 10.96% 14.11% 11.50% 8.40% 5.67%
Return on Equity Simple (ROE_SIMPLE)
11.73% 10.60% 10.42% 11.53% 11.98% 12.02% 10.38% 13.21% 10.73% 6.06% 5.06%
Net Operating Profit after Tax (NOPAT)
4.24 4.33 5.01 6.73 7.91 9.00 8.64 12 13 15 14
NOPAT Margin
3.43% 3.54% 3.48% 4.33% 4.92% 5.20% 4.99% 5.95% 5.58% 5.64% 5.08%
Net Nonoperating Expense Percent (NNEP)
2.20% 1.33% 2.16% 3.30% 3.62% 3.71% 3.00% 2.22% 4.62% 11.99% -426.20%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - - 4.43%
Cost of Revenue to Revenue
76.47% 76.16% 75.70% 75.87% 75.55% 75.46% 73.39% 71.49% 70.35% 67.70% 67.87%
SG&A Expenses to Revenue
6.80% 7.52% 7.28% 7.64% 7.56% 7.88% 9.98% 11.54% 11.86% 13.61% 13.73%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
18.05% 18.68% 18.79% 18.32% 18.09% 18.27% 20.22% 21.61% 22.60% 24.67% 25.71%
Earnings before Interest and Taxes (EBIT)
6.42 6.01 7.16 7.95 9.24 9.73 9.98 14 16 19 18
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
9.51 9.95 13 14 16 16 18 24 27 33 37
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 2.78 2.79 5.27 6.48 6.59 4.37 2.38
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 8.35 10.65 16.30 87.08 39.84 9.88 12.38
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.00 1.03 1.08 2.28 2.72 2.85 3.79 2.45
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 23.19 23.20 50.81 49.05 61.40 72.09 47.06
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 4.31% 4.31% 1.97% 2.04% 1.63% 1.39% 2.12%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 2.33 2.24 4.14 4.54 4.78 4.91 2.25
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.00 1.16 1.25 2.44 2.95 3.05 3.67 2.57
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 11.92 13.24 24.08 25.68 26.21 28.86 19.38
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 20.13 22.30 42.36 43.23 44.26 48.95 39.04
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 23.49 24.12 48.93 49.60 54.66 65.08 50.46
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 14.80 18.77 17.89 34.35 41.52 29.21 18.32
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 109.92 0.00 119.53 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.35 0.49 0.63 0.45 0.35 0.45 0.37 0.56 0.49 0.02 0.11
Long-Term Debt to Equity
0.35 0.49 0.60 0.40 0.32 0.42 0.34 0.54 0.47 0.01 0.11
Financial Leverage
0.31 0.42 0.55 0.51 0.38 0.40 0.40 0.46 0.51 0.05 0.00
Leverage Ratio
1.80 1.90 2.05 1.99 1.82 1.84 1.83 1.92 2.01 1.49 1.31
Compound Leverage Factor
1.80 1.90 2.05 1.99 1.82 1.84 1.83 1.81 1.70 1.41 1.32
Debt to Total Capital
26.18% 32.89% 38.62% 30.80% 26.05% 31.14% 26.82% 35.99% 33.02% 1.81% 10.23%
Short-Term Debt to Total Capital
0.00% 0.00% 2.02% 2.89% 2.36% 2.03% 2.01% 1.61% 1.51% 1.02% 0.57%
Long-Term Debt to Total Capital
26.18% 32.89% 36.60% 27.91% 23.69% 29.11% 24.81% 34.38% 31.51% 0.79% 9.67%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
73.82% 67.11% 61.38% 69.20% 73.95% 68.86% 73.18% 64.01% 66.98% 98.19% 89.77%
Debt to EBITDA
1.28 1.92 2.05 1.64 1.35 1.85 1.57 2.06 1.83 0.13 0.89
Net Debt to EBITDA
1.27 1.85 1.98 1.60 1.30 1.82 1.54 2.00 1.77 -0.94 0.85
Long-Term Debt to EBITDA
1.28 1.92 1.94 1.49 1.22 1.73 1.45 1.96 1.75 0.06 0.84
Debt to NOPAT
2.87 4.41 5.45 3.40 2.65 3.37 3.18 3.97 3.81 0.28 2.31
Net Debt to NOPAT
2.85 4.26 5.29 3.31 2.55 3.32 3.12 3.86 3.70 -2.12 2.20
Long-Term Debt to NOPAT
2.87 4.41 5.17 3.08 2.41 3.15 2.95 3.79 3.64 0.12 2.18
Altman Z-Score
0.00 0.00 0.00 0.00 4.79 4.21 6.50 5.75 6.28 11.28 5.52
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.27 1.66 1.80 1.92 2.03 2.32 1.95 2.15 2.39 3.14 2.29
Quick Ratio
1.52 1.18 1.22 1.26 1.33 1.56 1.39 1.50 1.65 2.49 1.70
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-4.53 -6.60 -7.52 2.98 1.69 -8.09 3.54 -19 -1.11 -32 -110
Operating Cash Flow to CapEx
128.70% 269.83% 145.33% 168.18% 179.91% 180.78% 358.17% 175.43% 180.25% 245.60% 322.27%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -23.45 -0.46 -17.60 -137.55
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 21.75 7.01 17.77 48.85
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.35 3.12 10.54 33.69
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
2.13 1.76 1.70 1.64 1.59 1.48 1.33 1.32 1.23 1.07 0.83
Accounts Receivable Turnover
7.10 6.78 6.98 6.29 5.89 5.71 5.22 5.49 5.39 5.55 5.32
Inventory Turnover
14.62 14.02 12.97 10.27 9.02 9.17 9.86 12.04 10.95 10.23 11.85
Fixed Asset Turnover
15.00 11.25 10.32 9.50 8.76 8.55 8.06 8.43 8.31 7.63 6.26
Accounts Payable Turnover
12.75 11.75 11.03 9.36 8.65 9.85 10.50 11.08 10.80 12.84 13.38
Days Sales Outstanding (DSO)
51.40 53.83 52.30 58.02 61.96 63.96 69.98 66.49 67.67 65.75 68.56
Days Inventory Outstanding (DIO)
24.96 26.03 28.14 35.55 40.47 39.80 37.03 30.33 33.35 35.68 30.81
Days Payable Outstanding (DPO)
28.62 31.06 33.10 39.00 42.20 37.05 34.75 32.94 33.80 28.43 27.28
Cash Conversion Cycle (CCC)
47.74 48.79 47.34 54.57 60.24 66.71 72.26 63.88 67.23 73.01 72.09
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
46 57 70 74 80 97 102 133 147 194 318
Invested Capital Turnover
2.94 2.35 2.26 2.16 2.10 1.96 1.74 1.74 1.64 1.52 1.09
Increase / (Decrease) in Invested Capital
8.77 11 13 3.75 6.22 17 5.11 31 14 47 124
Enterprise Value (EV)
0.00 0.00 0.00 0.00 186 217 423 605 704 953 714
Market Capitalization
0.00 0.00 0.00 0.00 166 187 396 558 656 984 683
Book Value per Share
$5.05 $5.65 $6.21 $7.21 $8.27 $9.09 $10.08 $11.46 $13.18 $25.50 $30.82
Tangible Book Value per Share
$1.45 $0.23 $0.48 $1.84 $2.75 $2.38 $3.26 $0.85 $2.18 $11.28 $5.93
Total Capital
46 58 71 74 81 97 103 135 149 229 320
Total Debt
12 19 27 23 21 30 28 48 49 4.16 33
Total Long-Term Debt
12 19 26 21 19 28 25 46 47 1.82 31
Net Debt
12 18 26 22 20 30 27 47 48 -31 31
Capital Expenditures (CapEx)
3.45 4.07 5.19 5.87 6.98 6.40 6.60 10 9.40 13 12
Debt-free, Cash-free Net Working Capital (DFCFNWC)
15 9.75 16 21 24 29 25 33 40 39 44
Debt-free Net Working Capital (DFNWC)
15 10 17 22 25 30 26 34 42 74 46
Net Working Capital (NWC)
15 10 16 19 23 28 24 32 39 72 44
Net Nonoperating Expense (NNE)
0.22 0.20 0.49 0.80 0.77 0.93 0.85 0.82 2.19 0.99 -0.36
Net Nonoperating Obligations (NNO)
12 18 26 22 20 30 27 47 48 -31 31
Total Depreciation and Amortization (D&A)
3.09 3.95 6.18 5.99 6.36 6.66 7.58 9.57 11 14 19
Debt-free, Cash-free Net Working Capital to Revenue
12.25% 7.98% 11.41% 13.49% 14.90% 16.77% 14.59% 15.98% 17.35% 14.96% 15.90%
Debt-free Net Working Capital to Revenue
12.30% 8.50% 12.00% 13.86% 15.39% 17.05% 14.92% 16.66% 18.01% 28.52% 16.45%
Net Working Capital to Revenue
12.30% 8.50% 11.00% 12.48% 14.21% 15.91% 13.72% 15.61% 17.04% 27.62% 15.79%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.59 $0.60 $0.65 $0.83 $0.99 $1.10 $1.05 $1.52 $1.42 $1.66 $1.58
Adjusted Weighted Average Basic Shares Outstanding
6.80M 6.89M 6.99M 7.12M 7.20M 7.33M 7.42M 7.50M 7.55M 8.24M 9.19M
Adjusted Diluted Earnings per Share
$0.57 $0.58 $0.64 $0.81 $0.95 $1.08 $1.03 $1.50 $1.40 $1.63 $1.57
Adjusted Weighted Average Diluted Shares Outstanding
7.06M 7.12M 7.11M 7.30M 7.52M 7.49M 7.55M 7.59M 7.65M 8.35M 9.25M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.99 $1.10 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
6.87M 6.98M 7.11M 7.20M 7.30M 7.39M 7.47M 7.55M 7.64M 9.13M 9.32M
Normalized Net Operating Profit after Tax (NOPAT)
4.24 4.33 5.01 6.73 7.91 9.00 8.64 12 13 15 14
Normalized NOPAT Margin
3.43% 3.54% 3.48% 4.33% 4.92% 5.20% 4.99% 5.95% 5.58% 5.64% 5.08%
Pre Tax Income Margin
5.20% 4.92% 4.98% 5.12% 5.74% 5.62% 5.76% 6.44% 5.85% 7.11% 6.58%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 17.28 6.58 10.61 22.93
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 15.06 5.33 7.98 17.74
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.89 2.69 3.37 7.77
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.67 1.44 0.74 2.58
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
1.76% 3.25% 23.53% 7.60% 2.03% 34.98% 39.13% 58.73% 4.18% 35.95% 24.56%

Quarterly Metrics And Ratios for Transcat

This table displays calculated financial ratios and metrics derived from Transcat's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/24/2023 9/23/2023 12/23/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 12/27/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
10.86% 11.28% 13.53% 14.25% 10.08% 8.00% 2.44% 8.77% 14.57% 21.30% 25.62%
EBITDA Growth
20.97% -15.12% 36.91% 49.38% 23.28% 58.69% -2.97% -4.27% 16.84% 23.75% -4.07%
EBIT Growth
32.71% -45.23% 40.53% 54.72% 8.57% 107.03% -22.37% -26.91% 0.74% -5.99% -98.04%
NOPAT Growth
13.28% -65.94% 41.18% 48.79% 18.20% 250.76% -53.00% -25.00% -11.31% -33.68% -96.11%
Net Income Growth
-4.00% -80.48% 109.12% 88.35% 49.47% 614.35% -29.60% -35.21% -26.02% -61.38% -146.71%
EPS Growth
-5.00% -80.65% 80.95% 68.75% 26.32% 483.33% -34.21% -39.51% -27.08% -60.00% -148.00%
Operating Cash Flow Growth
268.87% 164.29% 24.91% 92.44% 18.42% -18.98% 15.40% 85.58% -59.40% 88.46% -3.60%
Free Cash Flow Firm Growth
66.39% -158.62% -113.10% -322.45% -533.56% -15.30% -208.31% -195.02% 4.80% -179.91% 41.93%
Invested Capital Growth
11.81% 33.79% 31.59% 31.88% 54.98% 30.29% 69.34% 63.83% 33.66% 62.22% 23.51%
Revenue Q/Q Growth
-2.37% 3.64% 3.76% 8.82% -5.93% 1.68% -1.58% 15.55% -0.92% 7.65% 1.93%
EBITDA Q/Q Growth
-20.19% -32.39% 55.98% 77.47% -34.13% -12.97% -4.63% 63.79% -14.05% -7.82% -26.07%
EBIT Q/Q Growth
-29.78% -63.02% 136.70% 151.76% -50.73% -29.49% -11.25% 116.11% -25.51% -34.21% -98.15%
NOPAT Q/Q Growth
-18.04% -74.09% 257.19% 96.17% -34.89% -23.11% -52.14% 213.05% -23.00% -42.51% -97.19%
Net Income Q/Q Growth
-19.38% -84.40% 627.83% 105.79% -36.02% -25.45% -28.27% 89.39% -26.95% -61.09% -186.76%
EPS Q/Q Growth
-20.83% -84.21% 533.33% 113.16% -40.74% -27.08% -28.57% 96.00% -28.57% -60.00% -185.71%
Operating Cash Flow Q/Q Growth
153.23% 11.94% 29.41% -47.54% 55.82% -23.41% 84.32% -15.64% -65.91% 255.53% -5.71%
Free Cash Flow Firm Q/Q Growth
-35.55% -264.19% 11.37% 3.45% -103.29% 33.72% -136.99% 7.61% 34.40% -94.86% 50.83%
Invested Capital Q/Q Growth
6.60% 21.26% -1.21% 3.27% 25.27% 1.94% 28.40% -0.09% 2.20% 23.73% -2.25%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
30.88% 32.04% 32.13% 33.89% 33.96% 31.27% 29.48% 33.59% 33.79% 32.53% 30.11%
EBITDA Margin
12.16% 7.93% 11.92% 19.44% 13.61% 11.65% 11.29% 16.00% 13.88% 11.89% 8.62%
Operating Margin
7.66% 2.62% 6.59% 12.98% 7.64% 5.51% 3.15% 9.00% 6.98% 4.26% 0.10%
EBIT Margin
7.55% 2.69% 6.15% 14.22% 7.45% 5.16% 4.66% 8.71% 6.55% 4.00% 0.07%
Profit (Net Income) Margin
4.87% 0.73% 5.14% 9.72% 6.61% 4.84% 3.53% 5.79% 4.27% 1.54% -1.31%
Tax Burden Percent
78.39% 57.36% 78.39% 71.74% 84.32% 88.50% 75.33% 71.36% 71.43% 62.54% 76.51%
Interest Burden Percent
82.21% 47.40% 106.64% 95.25% 105.23% 105.99% 100.64% 93.11% 91.21% 61.62% -2,359.02%
Effective Tax Rate
21.61% 42.64% 21.61% 28.26% 15.68% 11.50% 24.67% 28.64% 28.57% 37.46% 0.00%
Return on Invested Capital (ROIC)
9.55% 2.19% 7.83% 14.16% 8.56% 6.02% 2.55% 6.98% 5.06% 2.48% 0.07%
ROIC Less NNEP Spread (ROIC-NNEP)
8.13% 1.25% 7.62% 17.62% 9.36% 5.89% 25.39% -574.06% -3.14% 0.33% -1.67%
Return on Net Nonoperating Assets (RNNOA)
3.94% 0.55% 0.42% 0.90% 0.68% 0.45% 0.34% -0.19% -0.08% 0.05% -0.39%
Return on Equity (ROE)
13.49% 2.74% 8.24% 15.05% 9.24% 6.47% 2.89% 6.79% 4.98% 2.53% -0.32%
Cash Return on Invested Capital (CROIC)
-2.25% -21.98% -19.71% -18.92% -35.45% -18.30% -45.27% -42.86% -23.99% -43.55% -17.95%
Operating Return on Assets (OROA)
9.27% 3.01% 6.56% 15.27% 7.51% 4.89% 3.80% 7.21% 5.27% 3.00% 0.05%
Return on Assets (ROA)
5.97% 0.82% 5.48% 10.43% 6.66% 4.59% 2.88% 4.79% 3.43% 1.15% -0.98%
Return on Common Equity (ROCE)
13.49% 2.74% 8.24% 15.05% 9.24% 6.47% 2.89% 6.79% 4.98% 2.53% -0.32%
Return on Equity Simple (ROE_SIMPLE)
9.54% 6.27% 4.77% 0.00% 5.76% 6.67% 6.03% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
3.64 0.94 3.37 6.60 4.30 3.31 1.58 4.95 3.81 2.19 0.06
NOPAT Margin
6.00% 1.50% 5.17% 9.31% 6.45% 4.87% 2.37% 6.42% 4.99% 2.66% 0.07%
Net Nonoperating Expense Percent (NNEP)
1.42% 0.95% 0.21% -3.47% -0.80% 0.12% -22.84% 581.04% 8.20% 2.15% 1.74%
Return On Investment Capital (ROIC_SIMPLE)
- - 1.51% - - - 0.49% 1.55% 1.17% 0.54% 0.02%
Cost of Revenue to Revenue
69.12% 67.96% 67.87% 66.11% 66.04% 68.73% 70.52% 66.41% 66.21% 67.47% 69.89%
SG&A Expenses to Revenue
12.54% 18.51% 14.00% 9.82% 14.62% 13.70% 14.17% 12.62% 14.35% 15.35% 16.42%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
23.22% 29.43% 25.54% 20.91% 26.32% 25.76% 26.33% 24.60% 26.80% 28.27% 30.01%
Earnings before Interest and Taxes (EBIT)
4.58 1.69 4.01 10 4.97 3.50 3.11 6.72 5.01 3.29 0.06
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
7.37 4.98 7.77 14 9.08 7.90 7.54 12 11 9.78 7.23
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
6.02 5.28 4.35 4.37 4.17 4.13 3.47 2.38 2.70 2.32 1.85
Price to Tangible Book Value (P/TBV)
35.99 83.67 10.41 9.88 11.17 10.46 20.85 12.38 12.45 0.00 0.00
Price to Revenue (P/Rev)
2.82 3.01 3.79 3.79 4.12 4.11 3.58 2.45 2.74 2.27 1.72
Price to Earnings (P/E)
63.11 84.27 91.23 72.09 72.36 61.96 57.57 47.06 59.12 60.51 69.57
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
1.58% 1.19% 1.10% 1.39% 1.38% 1.61% 1.74% 2.12% 1.69% 1.65% 1.44%
Enterprise Value to Invested Capital (EV/IC)
4.54 4.11 4.89 4.91 4.42 4.40 3.18 2.25 2.53 1.97 1.64
Enterprise Value to Revenue (EV/Rev)
3.01 3.22 3.67 3.67 4.04 4.03 3.72 2.57 2.86 2.62 2.02
Enterprise Value to EBITDA (EV/EBITDA)
25.34 28.72 31.34 28.86 30.93 28.96 27.06 19.38 21.43 19.71 16.17
Enterprise Value to EBIT (EV/EBIT)
41.86 50.05 54.78 48.95 54.09 50.32 48.74 39.04 44.88 43.78 42.81
Enterprise Value to NOPAT (EV/NOPAT)
53.89 67.93 73.41 65.08 69.92 62.12 64.32 50.46 60.03 62.47 58.80
Enterprise Value to Operating Cash Flow (EV/OCF)
31.77 28.26 30.79 29.21 31.59 33.65 29.71 18.32 24.43 19.98 16.44
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.44 0.39 0.02 0.02 0.01 0.01 0.15 0.11 0.12 0.38 0.34
Long-Term Debt to Equity
0.42 0.37 0.01 0.01 0.00 0.00 0.14 0.11 0.11 0.38 0.34
Financial Leverage
0.48 0.44 0.05 0.05 0.07 0.08 0.01 0.00 0.02 0.15 0.23
Leverage Ratio
1.92 1.89 1.50 1.49 1.41 1.40 1.34 1.31 1.29 1.43 1.49
Compound Leverage Factor
1.58 0.89 1.60 1.42 1.49 1.49 1.34 1.22 1.18 0.88 -35.06
Debt to Total Capital
30.40% 27.82% 2.12% 1.81% 1.35% 1.10% 12.97% 10.23% 10.52% 27.47% 25.18%
Short-Term Debt to Total Capital
1.43% 1.20% 1.04% 1.02% 0.89% 0.88% 0.75% 0.57% 0.37% 0.00% 0.00%
Long-Term Debt to Total Capital
28.97% 26.63% 1.08% 0.79% 0.46% 0.23% 12.23% 9.67% 10.15% 27.47% 25.18%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
69.60% 72.18% 97.88% 98.19% 98.65% 98.90% 87.03% 89.77% 89.48% 72.53% 74.82%
Debt to EBITDA
1.72 1.96 0.16 0.13 0.10 0.08 1.12 0.89 0.90 2.78 2.50
Net Debt to EBITDA
1.64 1.91 -1.04 -0.94 -0.55 -0.55 1.00 0.85 0.85 2.65 2.41
Long-Term Debt to EBITDA
1.64 1.87 0.08 0.06 0.04 0.02 1.06 0.84 0.86 2.78 2.50
Debt to NOPAT
3.66 4.63 0.38 0.28 0.23 0.17 2.66 2.31 2.51 8.81 9.10
Net Debt to NOPAT
3.49 4.52 -2.43 -2.12 -1.24 -1.19 2.37 2.20 2.37 8.41 8.78
Long-Term Debt to NOPAT
3.48 4.43 0.19 0.12 0.08 0.03 2.51 2.18 2.42 8.81 9.10
Altman Z-Score
6.29 5.57 10.71 11.17 12.15 13.66 6.77 5.42 6.02 3.23 2.94
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.68 2.32 3.37 3.14 2.96 3.59 2.42 2.29 2.92 2.43 2.21
Quick Ratio
1.90 1.64 2.70 2.49 2.23 2.77 1.80 1.70 2.21 1.93 1.73
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-13 -47 -42 -40 -82 -54 -129 -119 -78 -152 -75
Operating Cash Flow to CapEx
272.35% 315.13% 298.69% 136.98% 242.90% 172.64% 439.11% 394.36% 78.80% 290.64% 453.34%
Free Cash Flow to Firm to Interest Expense
-15.90 -52.95 -515.64 0.00 -1,576.55 -714.94 -647.10 -252.60 -173.06 -119.85 -49.75
Operating Cash Flow to Interest Expense
9.26 9.48 134.78 0.00 171.62 89.93 63.31 22.56 8.03 10.15 8.08
Operating Cash Flow Less CapEx to Interest Expense
5.86 6.47 89.65 0.00 100.96 37.84 48.89 16.84 -2.16 6.66 6.30
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.23 1.12 1.07 1.07 1.01 0.95 0.82 0.83 0.80 0.75 0.74
Accounts Receivable Turnover
5.85 5.70 6.10 5.55 5.82 5.74 5.64 5.32 5.40 5.37 5.70
Inventory Turnover
10.99 10.38 10.39 10.23 10.68 11.64 12.32 11.85 11.67 14.29 16.17
Fixed Asset Turnover
8.24 7.66 7.65 7.63 6.98 6.51 6.21 6.26 5.87 5.73 5.92
Accounts Payable Turnover
0.00 12.90 13.63 12.84 14.44 14.22 13.41 13.38 14.74 14.39 12.83
Days Sales Outstanding (DSO)
62.44 64.05 59.86 65.75 62.72 63.58 64.69 68.56 67.62 68.02 64.02
Days Inventory Outstanding (DIO)
33.21 35.15 35.14 35.68 34.18 31.36 29.63 30.81 31.29 25.55 22.57
Days Payable Outstanding (DPO)
0.00 28.29 26.78 28.43 25.29 25.67 27.22 27.28 24.76 25.37 28.46
Cash Conversion Cycle (CCC)
95.65 70.91 68.21 73.01 71.62 69.27 67.09 72.09 74.14 68.19 58.13
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
157 190 188 194 243 248 318 318 325 402 393
Invested Capital Turnover
1.59 1.46 1.52 1.52 1.33 1.24 1.08 1.09 1.01 0.93 0.90
Increase / (Decrease) in Invested Capital
17 48 45 47 86 58 130 124 82 154 75
Enterprise Value (EV)
713 782 920 953 1,074 1,090 1,012 714 823 794 646
Market Capitalization
667 730 950 984 1,093 1,111 975 683 790 687 549
Book Value per Share
$14.49 $17.98 $24.75 $25.50 $28.72 $29.39 $30.55 $30.82 $31.40 $31.70 $31.81
Tangible Book Value per Share
$2.42 $1.14 $10.35 $11.28 $10.72 $11.62 $5.09 $5.93 $6.81 ($0.87) ($0.29)
Total Capital
159 192 223 229 266 272 323 320 327 407 397
Total Debt
48 53 4.73 4.16 3.58 3.00 42 33 34 112 100
Total Long-Term Debt
46 51 2.41 1.82 1.22 0.61 39 31 33 112 100
Net Debt
46 52 -30 -31 -19 -21 37 31 33 107 96
Capital Expenditures (CapEx)
2.77 2.68 3.66 4.18 3.67 3.96 2.87 2.70 4.60 4.43 2.68
Debt-free, Cash-free Net Working Capital (DFCFNWC)
40 38 37 39 42 47 43 44 52 45 41
Debt-free Net Working Capital (DFNWC)
42 39 72 74 65 71 47 46 54 50 44
Net Working Capital (NWC)
40 37 69 72 62 69 45 44 52 50 44
Net Nonoperating Expense (NNE)
0.69 0.48 0.02 -0.29 -0.11 0.02 -0.78 0.49 0.55 0.92 1.16
Net Nonoperating Obligations (NNO)
46 52 -30 -31 -19 -21 37 31 33 107 96
Total Depreciation and Amortization (D&A)
2.79 3.29 3.76 3.70 4.11 4.40 4.43 5.63 5.61 6.49 7.17
Debt-free, Cash-free Net Working Capital to Revenue
16.91% 15.69% 14.59% 14.96% 15.87% 17.45% 15.67% 15.90% 17.95% 14.99% 12.74%
Debt-free Net Working Capital to Revenue
17.82% 16.20% 28.63% 28.52% 24.40% 26.25% 17.37% 16.45% 18.60% 16.67% 13.82%
Net Working Capital to Revenue
16.86% 15.26% 27.71% 27.62% 23.51% 25.37% 16.49% 15.79% 18.18% 16.67% 13.82%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.39 $0.06 $0.39 $0.82 $0.49 $0.36 $0.26 $0.47 $0.35 $0.14 ($0.12)
Adjusted Weighted Average Basic Shares Outstanding
7.62M 7.82M 8.62M 8.24M 9.06M 9.16M 9.23M 9.19M 9.32M 9.32M 9.33M
Adjusted Diluted Earnings per Share
$0.38 $0.06 $0.38 $0.81 $0.48 $0.35 $0.25 $0.49 $0.35 $0.14 ($0.12)
Adjusted Weighted Average Diluted Shares Outstanding
7.76M 7.95M 8.75M 8.35M 9.20M 9.28M 9.33M 9.25M 9.39M 9.40M 9.33M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
7.69M 8.83M 8.83M 9.13M 9.15M 9.20M 9.31M 9.32M 9.32M 9.33M 9.33M
Normalized Net Operating Profit after Tax (NOPAT)
3.64 0.94 3.37 6.60 4.30 3.31 1.58 4.95 3.81 2.19 0.06
Normalized NOPAT Margin
6.00% 1.50% 5.17% 9.31% 6.45% 4.87% 2.37% 6.42% 4.99% 2.66% 0.07%
Pre Tax Income Margin
6.21% 1.28% 6.55% 13.54% 7.84% 5.47% 4.69% 8.11% 5.97% 2.47% -1.72%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
5.62 1.90 49.44 0.00 95.54 46.09 15.62 14.27 11.10 2.60 0.04
NOPAT to Interest Expense
4.47 1.06 41.56 0.00 82.68 43.49 7.95 10.51 8.46 1.73 0.04
EBIT Less CapEx to Interest Expense
2.22 -1.11 4.32 0.00 24.88 -6.00 1.21 8.54 0.90 -0.90 -1.74
NOPAT Less CapEx to Interest Expense
1.07 -1.95 -3.57 0.00 12.02 -8.60 -6.47 4.79 -1.74 -1.77 -1.74
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
2.94% 26.04% 21.67% 35.95% 41.20% 31.70% 34.63% 24.56% 14.56% 5.72% 5.75%

Financials Breakdown Chart

Key Financial Trends

Here is a concise, investor-focused read on Transcat Inc (TRNS) using the latest quarterly data across the last four years. The notes highlight notable trends in revenue, profitability, cash flow, and balance sheet strength.

  • Revenue growth into 2026: Revenue jumped to about $83.9 million in Q3 2026, up from roughly $66.8 million in Q3 2025, signaling stronger top-line momentum.
  • Robust quarterly operating cash flow in 2026: Net cash from continuing operating activities was around $12.1–12.9 million in recent quarters (e.g., Q3 2026 around $12.1M; Q2 2026 around $12.9M), indicating solid cash generation from core operations.
  • Substantial financing liquidity in mid-2026: Q2 2026 financing activity produced a large inflow (approximately $77 million), driven by debt issuance (~$128.7M) and a modest equity add (~$0.23M), providing liquidity to fund investing activities.
  • Healthy balance-sheet liquidity indicators: Total current assets were roughly $80–95 million in 2025–2026 with total current liabilities around $27–37 million, yielding a rough current ratio near 2x, suggesting solid short-term liquidity.
  • Stable equity base: Total equity remained strong around $292–297 million across recent periods, providing a substantial cushion against liabilities.
  • Net income is volatile quarter-to-quarter: Net income continuing operations fluctuates regionally (e.g., around a small gain earlier in 2026, but a slight loss in Q3 2026).
  • Cash balance varies in the low millions: Cash and equivalents at times hover in the low millions (e.g., about $1.9–5.1 million in 2025–2026), implying a tighter liquidity cushion outside peak financing periods.
  • Investing outflows tied to acquisitions and capex: Investing activities show meaningful cash outflows in several quarters (e.g., acquisitions and PPE purchases in 2025–2026), which can pressure near-term liquidity while potentially enabling growth.
  • Net income declined in Q3 2026: Net income continuing operations turned negative in Q3 2026 (around -$1.10 million), contrasting with prior quarters of positive earnings and raising concerns about near-term profitability stability.
  • Leverage and debt levels elevated: Long-term debt sits in the mid-to-high hundreds of thousands to ~$112 million range across 2025–2026, reflecting a meaningful leverage profile that could raise interest costs and refinancing risk if not managed.
05/07/26 02:23 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Transcat's Financials

When does Transcat's fiscal year end?

According to the most recent income statement we have on file, Transcat's financial year ends in March. Their financial year 2025 ended on March 29, 2025.

How has Transcat's net income changed over the last 10 years?

Transcat's net income appears to be on an upward trend, with a most recent value of $14.52 million in 2025, rising from $4.03 million in 2015. The previous period was $13.65 million in 2024. See Transcat's forecast for analyst expectations on what’s next for the company.

What is Transcat's operating income?
Transcat's total operating income in 2025 was $17.87 million, based on the following breakdown:
  • Total Gross Profit: $89.45 million
  • Total Operating Expenses: $71.58 million
How has Transcat's revenue changed over the last 10 years?

Over the last 10 years, Transcat's total revenue changed from $123.62 million in 2015 to $278.42 million in 2025, a change of 125.2%.

How much debt does Transcat have?

Transcat's total liabilities were at $98.36 million at the end of 2025, a 57.7% increase from 2024, and a 253.4% increase since 2015.

How much cash does Transcat have?

In the past 10 years, Transcat's cash and equivalents has ranged from $65 thousand in 2015 to $19.65 million in 2024, and is currently $1.52 million as of their latest financial filing in 2025.

How has Transcat's book value per share changed over the last 10 years?

Over the last 10 years, Transcat's book value per share changed from 5.05 in 2015 to 30.82 in 2025, a change of 510.4%.



Financial statements for NASDAQ:TRNS last updated on 2/6/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners